Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers.

Notaro S, Reimer D, Fiegl H, Schmid G, Wiedemair A, Rössler J, Marth C, Zeimet AG.

BMC Cancer. 2016 Aug 2;16:589. doi: 10.1186/s12885-016-2637-y.

2.

Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.

Schmid G, Notaro S, Reimer D, Abdel-Azim S, Duggan-Peer M, Holly J, Fiegl H, Rössler J, Wiedemair A, Concin N, Altevogt P, Marth C, Zeimet AG.

BMC Cancer. 2016 Feb 15;16:102. doi: 10.1186/s12885-016-2135-2.

3.

Ovarian cancer stem cells.

Zeimet AG, Reimer D, Sopper S, Boesch M, Martowicz A, Roessler J, Wiedemair AM, Rumpold H, Untergasser G, Concin N, Hofstetter G, Muller-Holzner E, Fiegl H, Marth C, Wolf D, Pesta M, Hatina J.

Neoplasma. 2012;59(6):747-55. doi: 10.4149/neo_2012_094. Review.

PMID:
22862176
4.

Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer.

Zeimet AG, Reimer D, Wolf D, Fiegl H, Concin N, Wiedemair A, Wolf AM, Rumpold H, Müller-Holzner E, Marth C.

Int J Cancer. 2009 May 15;124(10):2353-60. doi: 10.1002/ijc.24214.

5.

Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer.

Auer D, Reimer D, Porto V, Fleischer M, Roessler J, Wiedemair A, Marth C, Müller-Holzner E, Daxenbichler G, Zeimet AG.

Breast Cancer Res Treat. 2009 Jul;116(1):103-11. doi: 10.1007/s10549-008-0108-0. Epub 2008 Jul 10.

PMID:
18618240
6.

Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer.

Reimer D, Sadr S, Wiedemair A, Goebel G, Concin N, Hofstetter G, Marth C, Zeimet AG.

Ann N Y Acad Sci. 2006 Dec;1091:270-81.

PMID:
17341621
7.

Soluble isoforms but not the transmembrane form of coxsackie-adenovirus receptor are of clinical relevance in epithelial ovarian cancer.

Reimer D, Steppan I, Wiedemair A, Concin N, Hofstetter G, Marth C, Müller-Holzner E, Zeimet AG.

Int J Cancer. 2007 Jun 15;120(12):2568-75.

8.

Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients.

Reimer D, Sadr S, Wiedemair A, Stadlmann S, Concin N, Hofstetter G, Müller-Holzner E, Marth C, Zeimet AG.

Clin Cancer Res. 2007 Jan 1;13(1):144-51.

9.

Heterogeneous cross-talk of E2F family members is crucially involved in growth modulatory effects of interferon-gamma and EGF.

Reimer D, Sadr S, Wiedemair A, Concin N, Hofstetter G, Marth C, Zeimet AG.

Cancer Biol Ther. 2006 Jul;5(7):771-6. Epub 2006 Jul 26.

PMID:
16721044
10.

Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history.

Widschwendter A, Brunhuber T, Wiedemair A, Mueller-Holzner E, Marth C.

J Clin Virol. 2004 Dec;31(4):292-7.

PMID:
15494272
11.

Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors.

Widschwendter A, Gattringer C, Ivarsson L, Fiegl H, Schneitter A, Ramoni A, Müller HM, Wiedemair A, Jerabek S, Müller-Holzner E, Goebel G, Marth C, Widschwendter M.

Clin Cancer Res. 2004 May 15;10(10):3396-400.

12.

A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer.

Müller HM, Widschwendter A, Fiegl H, Goebel G, Wiedemair A, Müller-Holzner E, Marth C, Widschwendter M.

Cancer Lett. 2004 Jun 25;209(2):231-6.

PMID:
15159026
13.

Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.

Widschwendter A, Müller HM, Hubalek MM, Wiedemair A, Fiegl H, Goebel G, Mueller-Holzner E, Marth C, Widschwendter M.

Gynecol Oncol. 2004 May;93(2):407-16.

PMID:
15099954
14.

DNA methylation in serum and tumors of cervical cancer patients.

Widschwendter A, Müller HM, Fiegl H, Ivarsson L, Wiedemair A, Müller-Holzner E, Goebel G, Marth C, Widschwendter M.

Clin Cancer Res. 2004 Jan 15;10(2):565-71.

15.

CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients.

Widschwendter A, Ivarsson L, Blassnig A, Müller HM, Fiegl H, Wiedemair A, Müller-Holzner E, Goebel G, Marth C, Widschwendter M.

Int J Cancer. 2004 Mar 20;109(2):163-6.

16.

Human papillomavirus DNA in sera of cervical cancer patients as tumor marker.

Widschwendter A, Blassnig A, Wiedemair A, Müller-Holzner E, Müller HM, Marth C.

Cancer Lett. 2003 Dec 30;202(2):231-9.

PMID:
14643453

Supplemental Content

Loading ...
Support Center